Elalfy, M
grant numbers R03EY035824, DP5OD029610, P30EY022589) and an unrestricted departmental grant from Research to Prevent Blindness (New York, NY, USA)
although, caspases 6, 8 and 9 may also be involved
Figure 5: Proposed mechanism of Graves' disease pathogenesis
Our answer is rarely stop. Its usually some version of: Stay on the therapeutic dose for at least 3 to 6 months past goal weight to consolidate the loss Step down carefully (if appropriate), watch the scale, and make adjustments as needed Extend the interval for patients maintaining well on any dose, high or low
By secreting Il-1, TNF and complement component subunit 1q, the activated microglia induce the formation of neurotoxic reactive astrocytes which lose the ability to support neuronal survival, outgrowth, synaptogenesis and phagocytosis, leading to the death of neurons and oligodendrocytes (Zhang L